| Return Create A Forum - Home | |
| --------------------------------------------------------- | |
| MS Speaks | |
| https://msspeaks.createaforum.com | |
| --------------------------------------------------------- | |
| ***************************************************** | |
| Return to: OCREVUS (ocrelizumab) | |
| ***************************************************** | |
| #Post#: 3346-------------------------------------------------- | |
| (Abst.) Are disease-modifying drugs for progressive MS worthwhil | |
| e? | |
| By: agate Date: July 12, 2021, 6:30 pm | |
| --------------------------------------------------------- | |
| From PubMed via Multiple Sclerosis and Related Disorders (July | |
| 3, 2021)--"Delaying the inevitable: Are disease-modifying drugs | |
| for progressive multiple sclerosis worthwhile?" | |
| The article concerns siponimod and ocrelizumab. This will also | |
| be posted in the Mayzent (siponimod) section. | |
| https://pubmed.ncbi.nlm.nih.gov/34247107/ | |
| ***************************************************** |